Cargando…

In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control

Obesity-related diseases are always the major health problems that concern the whole world. Serial studies have reported that obesity development is closely related to the out-of-control leptin encoded by the obesity gene (ob). The latest report declaimed “Less Is More,” a model explaining that part...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Feng, Du, Lihong, Wang, Ruyu, Han, Baoquan, Zhang, Xiaojun, Yao, Zhangzhang, Zhang, Wenqiang, Cai, Chang, Zhang, Zhiying, Xu, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237534/
https://www.ncbi.nlm.nih.gov/pubmed/35774455
http://dx.doi.org/10.3389/fmicb.2022.923656
_version_ 1784736817422008320
author Yue, Feng
Du, Lihong
Wang, Ruyu
Han, Baoquan
Zhang, Xiaojun
Yao, Zhangzhang
Zhang, Wenqiang
Cai, Chang
Zhang, Zhiying
Xu, Kun
author_facet Yue, Feng
Du, Lihong
Wang, Ruyu
Han, Baoquan
Zhang, Xiaojun
Yao, Zhangzhang
Zhang, Wenqiang
Cai, Chang
Zhang, Zhiying
Xu, Kun
author_sort Yue, Feng
collection PubMed
description Obesity-related diseases are always the major health problems that concern the whole world. Serial studies have reported that obesity development is closely related to the out-of-control leptin encoded by the obesity gene (ob). The latest report declaimed “Less Is More,” a model explaining that partial leptin reduction triggers leptin sensitization and contributes to obesity control. Here, we came up with a novel concept, in vivo protein interference (iPRTi), an interesting protein knock-down strategy for in vivo partial leptin reduction. First, the specific immune response against leptin induced by the oral administration of ob recombinant yeast was confirmed. Subsequentally, leptin resistance was observed in diet-induced obese mice, and oral administration with ob recombinant yeast declined the circulating leptin and reduced significantly the body weight gain. To further investigate whether the iPRTi strategy is capable of obesity management, the diet-induced obese mice were administrated with ob recombinant yeast. All the indexes examined including the circulating leptin, triglyceride, and total cholesterol, as well as food intake and weight gain, demonstrated a positive effect of the iPRTi strategy on obesity control. In short, this study provides a novel strategy for the potential application of recombinant yeast for the therapy of obese individuals with leptin resistance.
format Online
Article
Text
id pubmed-9237534
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92375342022-06-29 In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control Yue, Feng Du, Lihong Wang, Ruyu Han, Baoquan Zhang, Xiaojun Yao, Zhangzhang Zhang, Wenqiang Cai, Chang Zhang, Zhiying Xu, Kun Front Microbiol Microbiology Obesity-related diseases are always the major health problems that concern the whole world. Serial studies have reported that obesity development is closely related to the out-of-control leptin encoded by the obesity gene (ob). The latest report declaimed “Less Is More,” a model explaining that partial leptin reduction triggers leptin sensitization and contributes to obesity control. Here, we came up with a novel concept, in vivo protein interference (iPRTi), an interesting protein knock-down strategy for in vivo partial leptin reduction. First, the specific immune response against leptin induced by the oral administration of ob recombinant yeast was confirmed. Subsequentally, leptin resistance was observed in diet-induced obese mice, and oral administration with ob recombinant yeast declined the circulating leptin and reduced significantly the body weight gain. To further investigate whether the iPRTi strategy is capable of obesity management, the diet-induced obese mice were administrated with ob recombinant yeast. All the indexes examined including the circulating leptin, triglyceride, and total cholesterol, as well as food intake and weight gain, demonstrated a positive effect of the iPRTi strategy on obesity control. In short, this study provides a novel strategy for the potential application of recombinant yeast for the therapy of obese individuals with leptin resistance. Frontiers Media S.A. 2022-06-14 /pmc/articles/PMC9237534/ /pubmed/35774455 http://dx.doi.org/10.3389/fmicb.2022.923656 Text en Copyright © 2022 Yue, Du, Wang, Han, Zhang, Yao, Zhang, Cai, Zhang and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Yue, Feng
Du, Lihong
Wang, Ruyu
Han, Baoquan
Zhang, Xiaojun
Yao, Zhangzhang
Zhang, Wenqiang
Cai, Chang
Zhang, Zhiying
Xu, Kun
In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control
title In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control
title_full In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control
title_fullStr In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control
title_full_unstemmed In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control
title_short In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control
title_sort in vivo protein interference: oral administration of recombinant yeast-mediated partial leptin reduction for obesity control
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237534/
https://www.ncbi.nlm.nih.gov/pubmed/35774455
http://dx.doi.org/10.3389/fmicb.2022.923656
work_keys_str_mv AT yuefeng invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT dulihong invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT wangruyu invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT hanbaoquan invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT zhangxiaojun invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT yaozhangzhang invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT zhangwenqiang invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT caichang invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT zhangzhiying invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol
AT xukun invivoproteininterferenceoraladministrationofrecombinantyeastmediatedpartialleptinreductionforobesitycontrol